Site Search
Professionals 857 results
Capabilities 83 results
Practice Area
Today’s legal and regulatory landscape is more fraught with risk than ever before. To survive—and thrive—in this challenging environment, sophisticated companies must have robust, proactive, and effective compliance programs in place.
Practice Area
Government Program Fraud, False Claims Act & Qui Tam Litigation
Investigations and litigation involving alleged fraud against the government pose a significant and growing threat to organizations and individuals across all industries that engage directly or indirectly in business with federal, state, and/or local governments. The government makes aggressive use of its extensive criminal and civil investigatory powers to root out alleged fraud and abuse implicating government funds, including one of its most powerful civil enforcement tools—the federal False Claims Act (FCA)—and similar state false claims statutes.
Industry
Winston has one of the world’s premier sports law practices. Our work has included some of the most famous legal matters in sports history—including Alston v. NCAA, the case that culminated in a 9–0 Supreme Court victory for the college players against the NCAA; the US$2.15B Los Angeles Dodgers acquisition; McNeil v. the NFL, the landmark antitrust jury trial that led to the establishment of free agency in the NFL; the multi-billion-dollar construction and permanent financings for SoFi Stadium; and Morgan v. USSF, the case that led to a historic equal pay settlement for the players on the Women’s National Team. Our work is transforming this global, multibillion-dollar industry.
Experience 59 results
Experience
|April 1, 2025
Experience
|March 18, 2025
Insights & News 3,575 results
Webinar
|August 21, 2025, 12:00 PM E.T.
Join our Financial Services Industry Group for a webinar focused on the key points in President Trump’s debanking executive order and recent debanking-related changes to the regulatory landscape. They will discuss expectations for debanking-related regulation and enforcement in the near future, as well as practical steps for financial institutions to manage associated risks and reduce the chances of becoming involved in debanking investigations. This webinar is part of a series covering the latest developments affecting our financial services clients.
Investigations, Enforcement, & Compliance Alerts
|August 18, 2025
|2 Min Read
PE Company on Hook for Portco’s False Claims Act Cybersecurity Violations
DOJ False Claims Act (FCA) settlements related to cybersecurity typically have focused on false representations by a government contractor of its compliance with cybersecurity requirements. A recently announced settlement shows that private equity owners are not immune from potential FCA liability.
Client Alert
|August 11, 2025
|9 Min Read
Debanking—closing accounts or refusing to open accounts for customers perceived to be high risk—has become a hotly debated topic in recent years among groups on both sides of the political aisle. The debate involves allegations that banks have improperly debanked customers for political, rather than risk-based, reasons. Such accusations have shined a spotlight on banks’ account management practices, resulting in changes to regulatory practices and a new executive order from President Trump requiring additional regulatory changes and investigations. All of which will mean increased risk for financial institutions.
Other Results 77 results
Site Content
Law Glossary
What Exclusivity Periods Are Associated with Biosimilars?
An applicant may not submit an aBLA until four years after the reference product is licensed by the FDA. (See BPCIA § 351(k).) Further, any biosimilar licenses “may not be made effective” until 12 years after the reference product was licensed. (See BPCIA § 351(l).)